Search clinical trials for: Placebo for atorvastatin

Total 70211 results

AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID); Pfizer

Completed

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

HIV-1 Infection

United States, Puerto Rico
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia (FIESTA)

Essential Hypertension, Dyslipidemia

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)

Hypercholesterolemia
Organon and Co

Completed

A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

Hypercholesterolemia
D. Walter Wray
US Department of Veterans Affairs

Recruiting

Novel Approaches for Improving Vascular Function in Veterans With HFpEF

Inflammation | HFpEF - Heart Failure With Preserved Ejection Fraction

United States
Pfizer

Completed

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins (SPIRE-SI)

Hyperlipidemia

United States, Canada
Juan D. Maya

Recruiting

Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease (ATOCHA)

Chronic Chagas Disease

Chile
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

Hypercholesterolemia

United States
St. Olavs Hospital
Ullevaal University Hospital; Oslo University Hospital; University Hospital of... and other collaborators

Not yet recruiting

Prophylactic Treatment With Atorvastatin for Episodic Migraine. (EStatinMig)

Episodic Migraine
Organon and Co

Completed

Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

Hypercholesterolemia
Organon and Co

Completed

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

Hypercholesterolemia

China
Inova Health Care Services

Completed

Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme (ArginineGBM)

Glioblastoma Multiforme

United States
Hotel Dieu de France Hospital
Pfizer; Nouvelle Société Française d'Athérosclérose

Completed

The HDL Particle Protection Study (HDL PROTECT)

Dyslipidemia in Patients With Diabetes Mellitus

Lebanon
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

ARREST PAD (Peripheral Arterial Disease)

Insulin Resistance | Intermittent Claudication | Arterial Occlusive Disease

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

Acute Upper Respiratory Infections

Russian Federation
Organon and Co

Completed

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

Hypercholesterolemia
Organon and Co

Completed

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

Hypercholesterolemia
Daewon Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Hypercholesterolemia, Dyslipidemia

Korea, Republic of
Makerere University
Vaccine and Gene Therapy Institute, Florida

Completed

Atorvastatin for HAART Suboptimal Responders

Acquired Immune Deficiency Syndrome Virus
NYU Langone Health

Terminated

Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus

Avascular Necrosis

United States
Tanta University

Completed

Statin Impact on Hepatic Decompensation

Quality of Life

Egypt
Sanofi
Regeneron Pharmaceuticals

Completed

Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY EAST)

Hypercholesterolemia

China, India, Thailand
Monash University
National Health and Medical Research Council, Australia; National Heart Foundation...

Active, not recruiting

A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) (STAREE)

Healthy | Elderly | Independent Living | Disability Free Survival

Australia
Scripps Health

Withdrawn

Is Myopathy Part of Statin Therapy (IMPOSTER-16)

Myopathic Conditions

United States
Hippocration General Hospital

Completed

Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

Coronary Artery Disease | Atherosclerosis | Endothelial Dysfunction | Oxidative Stress | HMG-CoA Reductase Inhibitor Toxicity

Greece
Astellas Pharma Inc

Completed

Special Drug Use-Results Survey of Lipitor Tablets (ALWAYS)

Hypercholesterolemia

Japan
Merck Sharp & Dohme LLC

Completed

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Dyslipidemia
Organon and Co

Completed

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd

Recruiting

A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

Essential Hypertension | Primary Hypercholesterolemia

Korea, Republic of
Organon and Co

Completed

Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

Hypercholesterolemia
University of Florida

Completed

Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Pfizer

Completed

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Hyperlipidemia

United States, Germany, Norway, Belgium, Korea, Republic of, Mexico, Sweden, United Kingdom
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia (HS-25-C-01)

Primary Hypercholesterolemia
Hospital de Clinicas de Porto Alegre

Unknown

Statin for Immunomudulation in Sepsis

Sepsis

Brazil
Eli Lilly and Company

Completed

A Study of LY2484595 in Patients With High LDL-C or Low HDL-C

Dyslipidemia

United States, Netherlands, Germany, Denmark, Poland, United Kingdom
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
EnnovaBio Australia Pharmaceuticals Pty Ltd

Not yet recruiting

A First-in-Human SAD/MAD Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ENC1018 in Healthy Adult Subjects

Healthy
National Institute of Allergy and Infectious Diseases...

Completed

Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy (STATIN)

HIV

United States
University of Calgary
Heart and Stroke Foundation of Ontario

Completed

High-Density Lipoprotein (HDL) Modulation and Endothelial Function

Atherosclerosis

Canada
ZYUS Life Sciences Inc.
Novotech (Australia) Pty Limited; ZYUS Life Sciences Australia Pty Ltd

Completed

Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation (HOPE)

Healthy | Osteoarthritis

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Healthy Participants | Atopic Dermatitis Patients

China
Sun Yat-sen University

Unknown

Single Dose of Atorvastatin and Circulating Endothelial Microparticles

Hydroxymethylglutaryl-CoA Reductase Inhibitors | Endothelium
Beni-Suef University

Recruiting

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Breast Cancer

Egypt
Ankara University
Turkish Society of Hematology

Completed

Effects of Atorvastatin on Endothelial Progenitor Cells After Coronary Surgery

Coronary Artery Bypass Surgery | Elective Surgical Procedure

Turkey
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
Wenzhou Medical University

Terminated

The Therapeutic Effects of Statins and Berberine on the Hyperlipemia

Dyslipidemias

China
University of Oxford
Wellcome Trust

Completed

7-day Atorvastatin and Emotional Processing

Healthy

United Kingdom
Theravance Biopharma

Completed

SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects

Healthy

United States
IRCCS San Raffaele

Completed

Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome (L-arginine)

Metabolic Syndrome | Insulin Resistance | Endothelial Dysfunction | Impaired Glucose Tolerance

Italy
Chong Kun Dang Pharmaceutical

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of

3

Subscribe